Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 15, 2022 | Grant | $1.20M | 1 | National Institutes of Health (NIH) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health (NIH) | Yes | Grant |